
Jan 12 (Reuters) - Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off on Monday in San Francisco.
The medical device maker has been eyeing tuck-in deals as it seeks to diversify its portfolio, particularly in cardiology and neuroscience, with CEO Geoff Martha in November saying that they would prefer companies in "early stage or close to market."
The company's balance sheet gives it flexibility to execute a "meaningful number" of transactions without financial strain, Chief Financial Officer Thierry Piéton said at the J.P. Morgan healthcare conference on Monday.
"What's changing versus the last few years is coming back to doing more M&A," he said, adding that Medtronic's dividend policy remains unchanged.
Medtronic, which makes devices ranging from pacemakers to insulin pumps, reported a 3.7% rise in revenue to $33.6 billion in fiscal 2025.
The company is targeting deals in the low- to mid-single-digit billions of dollars, choosing targets that will supplement its internal R&D efforts, Martha said on Monday. The company has set up a new committee at the board level to move faster on deals, he added.
The executives said Medtronic is focused on two themes, expanding in areas where it already competes and acquiring enabling technologies for procedures such as cardiac ablation and surgical robotics.
The company has spent recent years improving operations by divesting non-core units and plans to spin off its diabetes business as MiniMed Group through a U.S. initial public offering following its struggles over the last few years.
It also added two new directors to its board last year after activist investor Elliott Investment Management emerged as one of its largest shareholders.
Medtronic now sees itself positioned to pursue strategic opportunities.
"We've earned the right to do these acquisition, and we've got the capacity, so we're going to step up," Piéton said.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona and Leroy Leo)
LATEST POSTS
- 1
‘It’s Israeli policy’: Report reveals abuse of Palestinians in prisons - 2
Hundreds of kilos of protected plant seized by Israel Nature and Parks Authority in Golan - 3
Mickey Lee of 'Big Brother' fame dead at 35 after flu complications, family says - 4
The Response to Independence from the rat race: Methodologies for Creating Financial momentum - 5
Creativity Revealed: A Survey of \Making Shocking Looks\ Cosmetics Item
David Duchovny's new thriller has him stripping down at 65. But its chilling premise hits close to home.
Catch the moon dancing with bright star Regulus tonight
Glamour Shots once ruled the mall. I went to one of the last ones standing.
I work with companies to confront addiction in the workplace. The hidden crisis is costing corporate America millions.
ACA subsidies latest: Making sense of what's happening with health care after Republicans revolt, forcing a vote on funding extension
Pat Finn, actor from 'The Middle,' dies at 60 after bladder cancer diagnosis
Taste the World: Five Food sources That Have Dazzled Worldwide Palates
Lucky airplane passengers capture NASA's Artemis 2 moon launch from the sky
EU Commission prepares €90bn Ukraine loan despite Hungary's veto













